View abstract

Cet abstract a été assigné à session AOB FP
TitreFirst year Experience with Ruthenium Brachytherapy in ocular melanoma @ UZLeuven.
ButTo evaluate the procedure and technique for ruthenium brachytherapy in ocular melanoma patients after the introduction in a tertiary care centre in February 2018.
MéthodesRetrospective analysis of our database and review of the detailed literature on ruthenium brachytherapy in ocular melanoma. Our department has tree ruthenium plaques (CCA, CCB and COB) that can be applied for different tumour sizes.
RésultatsBetween February and September 2018, 20 patients were treated with ruthenium brachytherapy: 4 conjunctival melanomas, 1 iris melanoma and 15 uveal melanomas. Application time differs from 6.8 to 226.1 hours, for a top dose of 100 Gy. In one patient a temporary vitreous haemorrhage occurred after the application (juxtapapillary tumour). In 2 patients a diplopia was found up to 1 month after the application. Taking into account the limited follow-up, no recurrences occurred.
ConclusionRuthenium brachytherapy is a good and safe procedure for the treatment of ocular melanoma.
Conflit d'intérêtNon
Auteur 1
NomMISSOTTEN
InitialesGS
InstitutDept Ophthalmology, Catholic University Hospitals Leuven
VilleLeuven
Auteur 2
NomVan Ginderdeuren
InitialesR
InstitutDept Ophthalmology and Anatomopathology, Catholic University Hospitals Leuven
VilleLeuven
Auteur 3
NomVan Limbergen
InitialesE
InstitutDept Radiotherapy, Catholic University Hospitals Leuven
VilleLeuven
Auteur 4
NomVan Calster
InitialesJ
InstitutDept Ophthalmology, Catholic University Hospitals Leuven
VilleLeuven
top ^